Africa News Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Currents.

Press releases published on June 23, 2026

Kenya’s Parliament urged to pass landmark bill to address discrimination against widows
MASI, dirham et banques marocaines : Youssef El Mansouri et Imane El Idrissi face aux pressions mondiales
مؤشر MASI والدرهم: Youssef El Mansouri وImane El Idrissi يحللان السوق لمغاربة العالم
BB Energy launches LPG distribution business in Zambia, expanding access to cleaner, more reliable energy
Equinox Gold Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders to Approve Business Combination with Orla Mining
Globex Mining Enterprises Announces Results of Annual Meeting
Historic Graduation at Ebenezer Baptist Church Celebrates Global Leaders and Scholars
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency
Demand for Dealer and Retailer Loyalty Programs Is Rising in 2026, Says Buyerr
LIFE’S MOMENTS BRINGS THE TRADITIONAL FAMILY PHOTO ALBUM INTO THE DIGITAL AGE
SK pharmteco kündigt SKyvec™ an: eine integrierte virale Vektorplattform mit hoher Ausbeute zur Beschleunigung der Gentherapie-Entwicklung vom Labor bis zum Patienten
SK pharmteco lance SKyvec™, une plateforme unifiée de vecteurs viraux à haut rendement destinée à accélérer le développement des thérapies géniques, de la fabrication au patient
SK pharmteco, 생산 단계부터 환자 치료 현장까지 유전자 치료제 개발 전주기를 지원하는 통합형 고수율 바이럴 벡터 플랫폼 SKyvec™ 출시
Sigmatic Sciences Powers AI Scientists with NVIDIA’s Latest BioNeMo Agentic Capabilities
SK pharmteco Announces SKyvec™, A Unified, High-Yield Viral Vector Platform Designed to Accelerate Gene Therapy Development from Batch to Bedside
Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space
Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa News Currents

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.